Cargando…
Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
ASCT2 (SLC1A5) is a sodium-dependent neutral amino acid transporter that controls amino acid homeostasis in peripheral tissues. In cancer, ASCT2 is up-regulated where it modulates intracellular glutamine levels, fueling cell proliferation. Nutrient deprivation via ASCT2 inhibition provides a potenti...
Autores principales: | Garibsingh, Rachel-Ann A., Ndaru, Elias, Garaeva, Alisa A., Shi, Yueyue, Zielewicz, Laura, Zakrepine, Paul, Bonomi, Massimiliano, Slotboom, Dirk J., Paulino, Cristina, Grewer, Christof, Schlessinger, Avner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449414/ https://www.ncbi.nlm.nih.gov/pubmed/34507995 http://dx.doi.org/10.1073/pnas.2104093118 |
Ejemplares similares
-
Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds
por: Ndaru, Elias, et al.
Publicado: (2019) -
Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018) -
A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2
por: Garaeva, Alisa A., et al.
Publicado: (2019) -
Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
por: Colas, Claire, et al.
Publicado: (2015) -
Conserved allosteric inhibition mechanism in SLC1 transporters
por: Dong, Yang, et al.
Publicado: (2023)